Last updated on
Anticoagulation Action Initiative
Hospitalized patients with acute medical illnesses are at significant risk for venous thromboembolism (VTE) during and after a hospital stay. Strategies for optimal pharmacologic VTE thromboprophylaxis are evolving but necessary to protect high-risk patients after hospital discharge.
NATF is proud to launch the Anticoagulation Action Initiative to help drive the appropriate use of VTE prophylaxis in medically ill patients. Developed by a panel of global experts, this consensus document explores the most recent data on extended-duration prophylaxis and serves as a practical, contemporary guide for frontline providers and stakeholders, including hospitalists, internal medicine practitioners, pharmacists, nurse practitioners, physician assistants, subspecialty clinicians, and hematology, pulmonary medicine, and cardiovascular medicine staff.
NATF Action Initiative Consensus Group Members
Ebrahim Barkoudah, MD, MPH (Chair)
Harvard Medical School
Brigham and Women’s Hospital
Geoffrey D. Barnes, MD, MSc
University of Michigan Medical School
Thomas Chen, MD, PharmD
University of Chicago Medicine
Jean M. Connors, MD
Harvard Medical School
Brigham and Women’s Hospital
Steven Deitelzweig, MD
Ochsner Clinic Foundation, Ochsner Health System
Margaret C. Fang, MD, MPH
University of California
John Fanikos, RPh, MBA
Massachusetts College of Pharmacy and Health Science
Brigham and Women’s Hospital
Samuel Z. Goldhaber, MD
Harvard Medical School
Brigham and Women’s Hospital
Jennifer N. Goldstein, MD, MSc
Christiana Care Health System
Paul Grant, MD
University of Michigan Medical School
Todd E.H. Hecht, MD
Perelman School of Medicine, University of Pennsylvania
Scott Kaatz, DO, MSc
Henry Ford Hospital
Wayne State University
Cheng-Kai Kao, MD
University of Chicago Medicine
Gregory Piazza, MD, MS
Harvard Medical School
Brigham and Women’s Hospital
Tea Ramishvili, MD
Christiana Care Health System
Christian T. Ruff, MD, MPH
Harvard Medical School
Brigham and Women’s Hospital
Jeffrey L. Schnipper, MD, MPH
Harvard Medical School
Brigham and Women’s Hospital
Aviva Schwartz, MA
North American Thrombosis Forum
A special thank you to the Initiative’s corporate sponsor:
